ADAMTS1 as an ECM-degrading protease that was shown to indirectly induce its prometastatic effects by cleaving its substrates such as proteoglycans in the ECM and liberating cancer cells from structural barriers. The gene discussed is ADAMTS1; the disease is cancer.